EP2990031 - Bibliographic data

FORME DE DOSAGE PARENTÉRAL DE LA NORÉPINÉPHRINE

Last update	08/07/2025
Legal status	Brevet déchu
Origin	Européen

(73) Holder	Sun Pharmaceutical Industries Ltd Sun House, Plot N°. 201 B/1 Western Express Highway Goregoan (E) 400063 Mumbai, Maharashtra Inde
(72) Inventors	Rakesh THUMMAR Sun Pharmaceutical Industries Ltd. near Pratham Enclave Tandalja Road 390 020 Gujarat Inde Shantaram PAWAR Sun Pharmaceutical Industries Ltd. near Pratham Enclave Tandalja Road 390 020 Gujarat Inde Prashant KANE Sun Pharmaceutical Industries Ltd. near Pratham Enclave Tandalja Road 390 020 Gujarat Inde Samarth KUMAR Sun Pharmaceutical Industries Ltd. near Pratham Enclave Tandalja Road 390 020 Gujarat Inde Milan Natvarbhai THAKKAR Sun Pharmaceutical Industries Ltd. near Pratham Enclave Tandalja Road 390 020 Gujarat Inde Kandarp Maheshkumar DAVE Sun Pharmaceutical Industries Ltd. near Pratham Enclave Tandalja Road 390 020 Gujarat Inde Subhas Balaram BHOWMICK Sun Pharmaceutical Industries Ltd. near Pratham Enclave Tandalja Road 390 020 Gujarat Inde
(74) Agent	Mail recipient Harrison IP Limited 3 Ebor House Millfield Lane Nether Poppleton York YO26 6QY Royaume-Uni

(21) Request number	EP15182596.5
(22) Request date	26/08/2015

(11) Publication number	EP2990031
Publication date	13/11/2019

(54) Title of the invention	FORME DE DOSAGE PARENTÉRAL DE LA NORÉPINÉPHRINE
(51) International classification	A61K 31/137, A61K 9/00, A61K 47/10
International classification (before reform)	None

Claimed priority	(31) Number: 2759MU2014 (32) Date: 28/08/2014 (33) Country: IN
Initial application	None
Divisional application	None

Expected annuity	Annuity: 6 - Amount: 120 € - Due date 31/08/2020 Surtax: 6 - Amount: 24 € - Due date 01/03/2021
Last annuity	None

Publication	None
History	Publication de la délivrance du brevet européen - Legal date 13/11/2019 Entrée en période de grâce du brevet d'invention - Legal date 01/09/2020 Déchéance du brevet d'invention après période de grâce - Legal date 31/08/2020